BridgeBio Pharma, Inc. (BBIO) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 1.18B | 753.68M | 839.38M | 912.28M | 695.17M | 720.69M | 444.58M | 616.24M | 783.42M | 477.59M | 587.67M | 432.88M |
| Cash & Short-Term Investments | 940.19M | 587.48M | 645.94M | 757.34M | 540.6M | 681.1M | 266.32M | 587.18M | 519.82M | 434.88M | 543.26M | 383.79M |
| Cash Only | 879.89M | 570.12M | 642.95M | 749.4M | 540.6M | 681.1M | 266.32M | 547.37M | 475.35M | 375.94M | 505.21M | 302.44M |
| Short-Term Investments | 60.3M | 17.36M | 2.99M | 7.94M | 0 | 0 | 0 | 39.81M | 44.47M | 58.95M | 38.05M | 81.36M |
| Accounts Receivable | 205.23M | 139.44M | 116.52M | 76.87M | 115.27M | 4.72M | 478K | 660K | 235.49M | 1.75M | 5.17M | 8.61M |
| Days Sales Outstanding | 79.74 | 76.37 | 73.7 | 79.07 | 46.29 | 40.67 | 19.16 | 4.96K | 51.13 | 182.44 | 154.99 | 537.21 |
| Inventory | 32.98M | 26.75M | 24.53M | 18.28M | 3.95M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | 257.84 | 153 | 300.01 | 276.9 | 134.85 | - | - | - | - | - | - | - |
| Other Current Assets | 0 | 0 | 52.4M | 59.79M | 3.23M | 3.83M | 177.78M | 28.4M | 131K | 27.65M | 16.65M | 19.93M |
| Total Non-Current Assets | 49.53M | 41.59M | 158.87M | 167.91M | 186.47M | 198.65M | 220.4M | 178.14M | 65.91M | 68.79M | 67.34M | 70.78M |
| Property, Plant & Equipment | 22.17M | 13.52M | 12.38M | 12.29M | 13.86M | 12.78M | 15.14M | 17.11M | 19.47M | 19.84M | 21.75M | 22.86M |
| Fixed Asset Turnover | 10.90x | 11.91x | 9.78x | 8.45x | 8.76x | 0.42x | 0.17x | 0.12x | 10.74x | 0.08x | 0.18x | 0.07x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 27.36M | 28.08M | 28.8M | 29.51M | 27.8M | 23.93M | 24.52M | 25.12M | 25.72M | 26.32M | 26.92M | 27.52M |
| Long-Term Investments | 63.11M | 81.44M | 92.17M | 109.7M | 128.19M | 143.75M | 160.44M | 119.15M | 3.94M | 3.74M | 500K | 800K |
| Other Non-Current Assets | -63.11M | -81.44M | 25.52M | 16.41M | 16.61M | 18.2M | 20.29M | 16.76M | 16.78M | 22.63M | 18.18M | 19.6M |
| Total Assets | 1.37B | 936.02M | 998.25M | 1.08B | 881.64M | 919.34M | 664.98M | 794.38M | 849.33M | 546.38M | 655.01M | 503.66M |
| Asset Turnover | 0.17x | 0.16x | 0.12x | 0.11x | 0.13x | 0.01x | 0.00x | 0.00x | 0.30x | 0.00x | 0.01x | 0.00x |
| Asset Growth % | 55.5% | 1.82% | 50.12% | 35.98% | 3.8% | 68.26% | 1.52% | 57.72% | 35.75% | -12.3% | -10.12% | -41.59% |
| Total Current Liabilities | 816.37M | 287.97M | 216.6M | 175.85M | 152.1M | 154.4M | 139.22M | 134.36M | 141.48M | 143.84M | 106.06M | 110.12M |
| Accounts Payable | 29.06M | 36.23M | 18.7M | 26.13M | 27.52M | 9.62M | 13.36M | 18.13M | 4.73M | 10.65M | 4.47M | 3.87M |
| Days Payables Outstanding | 281.81 | 163.89 | 314.26 | 668.35 | 633.36 | 507.26 | 2.42K | 1.74K | 1.17K | 1.16K | 642 | 603.88 |
| Short-Term Debt | 573.41M | 17.41M | 0 | 9.59M | 0 | 0 | 0 | 4.62M | 4.54M | 4.13M | 0 | 0 |
| Deferred Revenue (Current) | 17.89M | 20.27M | 9.09M | 10.54M | 0 | 0 | 11.77M | 15.1M | 13.96M | 6.1M | 0 | 0 |
| Other Current Liabilities | 196.01M | 214.06M | 64.76M | 85.52M | 16.12M | 16.2M | 43.54M | 67.46M | 81.31M | 61.47M | 12.59M | 16.84M |
| Current Ratio | 1.44x | 2.62x | 3.88x | 5.19x | 4.57x | 4.67x | 3.19x | 4.59x | 5.54x | 3.32x | 5.54x | 3.93x |
| Quick Ratio | 1.40x | 2.52x | 3.76x | 5.08x | 4.54x | 4.67x | 3.19x | 4.59x | 5.54x | 3.32x | 5.54x | 3.93x |
| Cash Conversion Cycle | 55.77 | 65.48 | 59.46 | -312.38 | -452.22 | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 2.82B | 2.72B | 2.7B | 2.68B | 2.37B | 2.22B | 1.74B | 1.74B | 1.74B | 1.75B | 1.74B | 1.74B |
| Long-Term Debt | 2.8B | 2.71B | 1.85B | 2.66B | 1.85B | 1.72B | 1.72B | 1.72B | 1.72B | 1.73B | 1.72B | 1.72B |
| Capital Lease Obligations | 14.22M | 3.81M | 3.43M | 4.03M | 4.92M | 4.7M | 5.83M | 7.06M | 8.3M | 8.98M | 9.81M | 10.92M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8.3M | 0 | 0 | 0 |
| Other Non-Current Liabilities | 229K | 244K | 836.8M | 545K | 515.16M | 496.47M | 377K | 485K | 595K | 9.36M | 11.79M | 13.33M |
| Total Liabilities | 3.64B | 3.01B | 2.92B | 2.86B | 2.52B | 2.38B | 1.88B | 1.88B | 1.89B | 1.89B | 1.85B | 1.85B |
| Total Debt | 3.38B | 2.73B | 1.86B | 2.68B | 1.86B | 1.73B | 1.73B | 1.73B | 1.73B | 1.74B | 1.74B | 1.73B |
| Net Debt | 2.5B | 2.16B | 1.22B | 1.93B | 1.32B | 1.05B | 1.46B | 1.18B | 1.25B | 1.36B | 1.23B | 1.43B |
| Debt / Equity | - | - | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | 891.58x | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | 646.43x | - | - | - |
| Interest Coverage | -2.01x | -15.44x | -14.89x | -3.83x | -3.02x | -7.93x | -6.12x | -2.29x | -0.54x | -7.40x | -7.84x | -6.80x |
| Total Equity | -2.27B | -2.08B | -1.92B | -1.78B | -1.64B | -1.46B | -1.22B | -1.08B | -1.04B | -1.34B | -1.19B | -1.35B |
| Equity Growth % | -38.52% | -42.5% | -57.81% | -64.35% | -58.04% | -8.57% | -2.07% | 19.82% | 14.56% | -7.84% | -5.61% | -32.97% |
| Book Value per Share | -11.65 | -10.53 | -10.09 | -9.33 | -8.62 | -7.69 | -6.46 | -5.77 | -5.80 | -7.70 | -7.31 | -8.41 |
| Total Shareholders' Equity | -2.27B | -2.08B | -1.93B | -1.79B | -1.65B | -1.47B | -1.23B | -1.09B | -1.05B | -1.35B | -1.21B | -1.36B |
| Common Stock | 204K | 202K | 200K | 198K | 197K | 196K | 195K | 194K | 193K | 181K | 180K | 168K |
| Retained Earnings | -3.99B | -3.82B | -3.63B | -3.45B | -3.26B | -3.1B | -2.83B | -2.67B | -2.6B | -2.56B | -2.39B | -2.22B |
| Treasury Stock | -405.78M | -323.28M | -323.28M | -323.28M | -323.28M | -275M | -275M | -275M | -275M | -275M | -275M | -275M |
| Accumulated OCI | -8K | 12K | 2K | 1K | 0 | 8K | 5K | -4K | 2K | 31K | 34K | 63K |
| Minority Interest | -951K | -570K | 10.34M | 9.44M | 9.73M | 10.29M | 11.53M | 10.83M | 12.67M | 11.72M | 13.81M | 12.38M |